Trailing-twelve-month (TTM) revenue is $439.68 Million with a year-over-year growth of +1.17%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q1 FY2026Period ended 2025-09-26 | $107,320,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-04 |
| Q2 FY2026Period ended 2025-12-26 | $111,472,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-03 |
| Q3 FY2026Period ended 2026-03-27 | $100,003,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-04 |
| Q4 FY2026Period ended 2026-07-03 | $120,887,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-27 |
| TTM revenue | $439,682,000 |
Current P/S: $269,554,893 market capitalization ÷ $439,682,000 TTM revenue = 0.61x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T13:44:58.000Z. Latest revenue period ended 2026-07-03.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q4 FY2026 (2026-07-03): $120.89M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T13:45:40.901Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-07-03 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-07-03 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-07-02 · USD | FY20222022-07-01 · USD | FY20232023-06-30 · USD | FY20242024-06-28 · USD | FY20252025-06-27 · USD | FY20262026-07-03 · USD |
|---|---|---|---|---|---|---|
| Product | $186M | $208M | $239M | $274M | $288M | $314M |
| Service | $89M | $95M | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-07-02 · USD | FY20222022-07-01 · USD | FY20232023-06-30 · USD | FY20242024-06-28 · USD | FY20252025-06-27 · USD | FY20262026-07-03 · USD |
|---|---|---|---|---|---|---|
| Africa and Middle East | $44M | $48M | $60M | $49M | $49M | $58M |
| Europe | N/A | $13M | $19M | $25M |
$439.68M
$439.68 Million
+1.17%
vs. $434.60M a year ago (TTM)
+9.84%
5 Year compound annual growth rate
1 Year
+1.17%
3 Year
+8.23%
5 Year
+9.84%
10 Year
+5.05%
15 Year
(1.78%)
20 Year
+3.02%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $439.68M | +$5.08M | +1.17% |
| 2025 | $434.61M | +$26.52M | +6.50% |
| 2024 | $408.08M | +$63.65M | +18.48% |
| 2023 | $344.43M | +$41.47M | +13.69% |
| 2022 | $302.96M | $0 | +0.00% |
| 2021 |
TTM Growth
+1.17%
3-Year CAGR
+8.23%
5-Year CAGR
+9.84%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T13:45:40.901Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $147M |
| $125M |
| $32M |
| $42M |
| Europe and Russia | $9M | N/A | N/A | N/A | N/A | N/A |
|---|
| Latin America and Asia Pacific | $39M | $43M | $65M | $129M | $146M | $120M |
|---|
| North America | $183M | $200M | $202M | $206M | $208M | $220M |
|---|
| $302.96M |
| +$64.32M |
| +26.95% |
| 2020 | $238.64M | ($5.22M) | (2.14%) |
| 2019 | $243.86M | +$1.35M | +0.56% |
| 2018 | $242.51M | +$632,000 | +0.26% |
| 2017 | $241.87M | ($26.82M) | (9.98%) |
